Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study

Background: Valve replacement is associated with worse outcomes in individuals who have end-stage renal disease (ESRD) and require a long-term renal replacement therapy. Prosthetic valve selection in patients with ESRD has remained controversial.Objective: We aimed to investigate long-term outcomes...

Full description

Bibliographic Details
Main Authors: Guan-Yi Li, Yun-Yu Chen, Fa-Po Chung, Kuo-Liong Chien, Chiao-Po Hsu, Yenn-Jiang Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.745370/full
_version_ 1818361473286537216
author Guan-Yi Li
Yun-Yu Chen
Yun-Yu Chen
Fa-Po Chung
Fa-Po Chung
Kuo-Liong Chien
Chiao-Po Hsu
Chiao-Po Hsu
Yenn-Jiang Lin
Yenn-Jiang Lin
author_facet Guan-Yi Li
Yun-Yu Chen
Yun-Yu Chen
Fa-Po Chung
Fa-Po Chung
Kuo-Liong Chien
Chiao-Po Hsu
Chiao-Po Hsu
Yenn-Jiang Lin
Yenn-Jiang Lin
author_sort Guan-Yi Li
collection DOAJ
description Background: Valve replacement is associated with worse outcomes in individuals who have end-stage renal disease (ESRD) and require a long-term renal replacement therapy. Prosthetic valve selection in patients with ESRD has remained controversial.Objective: We aimed to investigate long-term outcomes of mechanical and bioprosthetic valve replacement in individuals with ESRD.Methods: We conducted a population-based retrospective cohort study using data obtained from the Taiwan National Health Insurance Research Database. In total, 10,202 patients, including 912 ESRD and 9,290 non-ESRD patients, were selected after a 1:1 propensity-score matching based on the type of prosthetic valve used. The long-term mortality outcomes were then analyzed.Results: During a median follow-up period of 59.6 months, the Kaplan–Meier survival analysis revealed that ESRD patients who underwent mechanical valve replacement had higher rates of all-cause mortality and CV deaths than those who underwent bioprosthetic valve replacement (Log-rank test, p = 0.03 and 0.02, respectively). Multivariable regression analyses demonstrated that ESRD patients who underwent bioprosthetic valve replacement had lower rates of all-cause mortality (p < 0.001, hazard ratio: 0.88, 95% confidence interval: 0.82–0.93) and cardiovascular (CV) death (p < 0.001, hazard ratio: 0.83, 95% confidence interval: 0.76–0.90) than those who had mechanical valve replacement.Conclusion: Bioprosthetic valve replacement is significantly associated with lower rates of all-cause mortality and CV death in the ESRD population.
first_indexed 2024-12-13T21:17:14Z
format Article
id doaj.art-fa52380d6c384ec2be5886cec25113fc
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-13T21:17:14Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-fa52380d6c384ec2be5886cec25113fc2022-12-21T23:31:13ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-12-01810.3389/fcvm.2021.745370745370Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective StudyGuan-Yi Li0Yun-Yu Chen1Yun-Yu Chen2Fa-Po Chung3Fa-Po Chung4Kuo-Liong Chien5Chiao-Po Hsu6Chiao-Po Hsu7Yenn-Jiang Lin8Yenn-Jiang Lin9Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanInstitute of Epidemiology and Preventive Medicine College of Public Health, National Taiwan University, Taipei, TaiwanDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanCardiovascular Research Center, Institute of Clinical Medicine, National Yang-Ming University, Taipei, TaiwanInstitute of Epidemiology and Preventive Medicine College of Public Health, National Taiwan University, Taipei, TaiwanCardiovascular Research Center, Institute of Clinical Medicine, National Yang-Ming University, Taipei, TaiwanDivision of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, TaiwanDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanCardiovascular Research Center, Institute of Clinical Medicine, National Yang-Ming University, Taipei, TaiwanBackground: Valve replacement is associated with worse outcomes in individuals who have end-stage renal disease (ESRD) and require a long-term renal replacement therapy. Prosthetic valve selection in patients with ESRD has remained controversial.Objective: We aimed to investigate long-term outcomes of mechanical and bioprosthetic valve replacement in individuals with ESRD.Methods: We conducted a population-based retrospective cohort study using data obtained from the Taiwan National Health Insurance Research Database. In total, 10,202 patients, including 912 ESRD and 9,290 non-ESRD patients, were selected after a 1:1 propensity-score matching based on the type of prosthetic valve used. The long-term mortality outcomes were then analyzed.Results: During a median follow-up period of 59.6 months, the Kaplan–Meier survival analysis revealed that ESRD patients who underwent mechanical valve replacement had higher rates of all-cause mortality and CV deaths than those who underwent bioprosthetic valve replacement (Log-rank test, p = 0.03 and 0.02, respectively). Multivariable regression analyses demonstrated that ESRD patients who underwent bioprosthetic valve replacement had lower rates of all-cause mortality (p < 0.001, hazard ratio: 0.88, 95% confidence interval: 0.82–0.93) and cardiovascular (CV) death (p < 0.001, hazard ratio: 0.83, 95% confidence interval: 0.76–0.90) than those who had mechanical valve replacement.Conclusion: Bioprosthetic valve replacement is significantly associated with lower rates of all-cause mortality and CV death in the ESRD population.https://www.frontiersin.org/articles/10.3389/fcvm.2021.745370/fullbioprosthetic valvecardiovascular eventend-stage renal diseasevalve replacementmechanical valvemortality
spellingShingle Guan-Yi Li
Yun-Yu Chen
Yun-Yu Chen
Fa-Po Chung
Fa-Po Chung
Kuo-Liong Chien
Chiao-Po Hsu
Chiao-Po Hsu
Yenn-Jiang Lin
Yenn-Jiang Lin
Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
Frontiers in Cardiovascular Medicine
bioprosthetic valve
cardiovascular event
end-stage renal disease
valve replacement
mechanical valve
mortality
title Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
title_full Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
title_fullStr Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
title_full_unstemmed Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
title_short Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
title_sort long term outcomes of bioprosthetic or mechanical valve replacement in end stage renal disease a nationwide population based retrospective study
topic bioprosthetic valve
cardiovascular event
end-stage renal disease
valve replacement
mechanical valve
mortality
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.745370/full
work_keys_str_mv AT guanyili longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT yunyuchen longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT yunyuchen longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT fapochung longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT fapochung longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT kuoliongchien longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT chiaopohsu longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT chiaopohsu longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT yennjianglin longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy
AT yennjianglin longtermoutcomesofbioprostheticormechanicalvalvereplacementinendstagerenaldiseaseanationwidepopulationbasedretrospectivestudy